Home › Therapeutic areas › Metabolic › Prader-Willi Syndrome
Prader-Willi Syndrome (2 companies)
Companies with an active program in Prader-Willi Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| RLMD | Relmada Therapeutics | MetabolicOncology Rare | 1 | Phase 2 | 4 |
| RYTM | Rhythm Pharmaceuticals | Metabolic Rare | 2 | Approved | 13 |
No companies match.